Impact of global and conditional genetic deletion of inducible nitric oxide synthase (iNOS) * on pulmonary hypertension (PH): insights from preclinical murine models resembling different clinical PH groups **. This evidence concerns the gene NOS2 and pulmonary arterial hypertension.